Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genzyme Wait for Higher Bid Risky Due to FDA Plant Deadline, Orbimed Says
Genzyme Wait for Higher Bid Risky Due to FDA Plant Deadline, Orbimed Says
Genzyme Wait for Higher Bid Risky Due to FDA Plant Deadline, Orbimed Says
Submitted by
admin
on November 18, 2010 - 9:39am
Source:
Bloomberg
News Tags:
M&A
Genzyme
Sanofi
Headline:
Genzyme Wait for Higher Bid Risky Due to FDA Plant Deadline, Orbimed Says
Do Not Allow Advertisers to Use My Personal information
